The Cooper Companies, Inc. (NASDAQ:COO) Receives $117.00 Average Target Price from Analysts

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twelve ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $117.00.

A number of analysts have issued reports on COO shares. Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a report on Tuesday, September 10th. StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday. Stifel Nicolaus reissued a "buy" rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Thursday, August 29th.

Insider Activity

In related news, CFO Brian G. Andrews sold 24,788 shares of the firm's stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares of the company's stock, valued at approximately $700,422.60. This trade represents a 78.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at approximately $520,488.54. This trade represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 256,373 shares of company stock valued at $27,637,427. Insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Cooper Companies

Several large investors have recently modified their holdings of the stock. LRI Investments LLC grew its position in Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company's stock worth $227,000 after purchasing an additional 112 shares during the last quarter. Mitchell & Pahl Private Wealth LLC boosted its holdings in Cooper Companies by 1.5% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock valued at $881,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Cooper Companies by 0.8% in the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company's stock valued at $1,362,000 after buying an additional 118 shares during the last quarter. Bleakley Financial Group LLC grew its stake in shares of Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock valued at $636,000 after buying an additional 119 shares in the last quarter. Finally, First Horizon Advisors Inc. increased its stake in Cooper Companies by 4.8% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock worth $236,000 after buying an additional 125 shares during the period. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $0.03 during mid-day trading on Wednesday, reaching $99.08. 898,934 shares of the stock traded hands, compared to its average volume of 1,123,666. The business has a 50-day moving average of $106.29 and a 200 day moving average of $98.19. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $19.73 billion, a PE ratio of 55.04, a PEG ratio of 2.15 and a beta of 0.99. Cooper Companies has a fifty-two week low of $82.21 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies's revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 EPS. On average, analysts predict that Cooper Companies will post 3.65 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.